For the quarter ending 2025-08-31, CCEL had $127,716 increase in cash & cash equivalents over the period. $2,497,928 in free cash flow.
| Cash Flow | 2025-08-31 | 2025-05-31 |
|---|---|---|
| Net income | 749,408 | 638,640 |
| Depreciation and amortization expense | 244,090 | 498,141 |
| Impairment of investment - tianhe stock | 0 | 0 |
| Loss on sale of property and equipment | -633 | -47,671 |
| Losses (gains) on marketable securities | -193,886 | -410,733 |
| Unrealized gain on interest rate swap contract | 0 | 0 |
| Compensatory element of stock options | 36,780 | 337,418 |
| Provision for doubtful accounts | 413,611 | 366,586 |
| Amortization of debt issuance costs | 5,192 | 10,465 |
| Amortization of operating lease right-of-use asset | 109,540 | 186,114 |
| Accounts receivable | 315,517 | -11,034 |
| Prepaid expenses | -3,415 | -15,710 |
| Inventory | -21,511 | -58,219 |
| Other current assets | -47,339 | -62,265 |
| Deposits and other assets, net | 30,450 | 61,694 |
| Accounts payable | 370,475 | 370,932 |
| Accrued expenses | -389,123 | -3,136,174 |
| Operating lease liability | -114,728 | -203,016 |
| Other liabilities | 0 | 0 |
| Deferred revenue | 1,190,654 | 2,048,033 |
| Net cash from operating activities | 2,536,716 | 1,661,077 |
| Purchases of property and equipment | 38,788 | 124,461 |
| Sale of property and equipment | 0 | 115,000 |
| Payment of duke license agreement | 0 | 0 |
| Proceeds from liquidation of marketable securities | 0 | - |
| Purchases of marketable securities | 585,896 | 2,574,249 |
| Sale of marketable securities | 1,729,285 | 793,426 |
| Net cash used in investing activities | 1,104,601 | -1,790,284 |
| Treasury stock purchases | 80,883 | 88,619 |
| Repayments of note payable | 35,819 | 74,416 |
| Repayment of line of credit | 3,420,000 | 3,700,000 |
| Proceeds from the exercise of stock options | 23,101 | - |
| Proceeds from line of credit | 0 | 6,800,000 |
| Dividends paid | 0 | 3,231,227 |
| Proceeds from swap termination | 0 | 0 |
| Net cash used in financing activities | -3,513,601 | -294,262 |
| Decrease in cash and cash equivalents | 127,716 | -423,469 |
| Cash and cash equivalents at beginning of period | 560,960 | - |
| Cash and cash equivalents at end of period | 265,207 | - |
CRYO CELL INTERNATIONAL INC (CCEL)
CRYO CELL INTERNATIONAL INC (CCEL)